Ibrutinib treatment in Waldenström's macroglobulinemia (WM): Follow-up results of the phase 3 iNNOVATE™ study Meeting Abstract
| Authors: | Buske, C.; Tedeschi, A.; Trotman, J.; Garcia-Sanz, R.; Macdonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C. S.; Palomba, M. L.; Matous, J. V.; Shustik, C.; Kastritis, E.; Treon, S. P.; Lih, C. J.; Li, J.; Salman, Z.; Graef, T.; Dimopoulos, M. A. |
| Abstract Title: | Ibrutinib treatment in Waldenström's macroglobulinemia (WM): Follow-up results of the phase 3 iNNOVATE™ study |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 42 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Oct 11-14 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2019-10-01 |
| Start Page: | 158 |
| Language: | English |
| ACCESSION: | WOS:000568159600384 |
| PROVIDER: | wos |
| DOI: | 10.1159/000502425 |
| Notes: | "Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Meeting Abstract: V603 -- Source: Wos |
